HUTCHMED (China) (HCM) Operating Expenses (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Operating Expenses of -$19.8 million for Q2 2021, up 80.4% year-over-year from -$11.0 million in Q2 2020, and up 86.35% quarter-over-quarter from -$144.8 million in Q1 2021.
HUTCHMED (China) (HCM) Operating Expenses (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Operating Expenses for 4 consecutive years, with -$19.8 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Operating Expenses rose 80.4% year-over-year to -$19.8 million; the TTM figure through Dec 2022 stood at -$19.8 million (up 87.99% YoY), while the FY2025 annual figure was -$75.6 million, up 12.51% from the prior year.
- Operating Expenses advanced to -$19.8 million in Q2 2021 per HCM's latest filing, from -$144.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $233.2 million in Q2 2018 and bottomed at -$262.4 million in Q2 2019.
- Historically, Operating Expenses has averaged -$32.8 million across 4 years, with a median of -$80.7 million in 2018.
- On a YoY basis, Operating Expenses climbed as much as 214.04% in 2019 and fell as far as 218.76% in 2019.
- HUTCHMED (China)'s Operating Expenses stood at $77.3 million in 2018, then plunged by 218.76% to -$91.8 million in 2019, then decreased by 9.9% to -$100.9 million in 2020, then surged by 80.4% to -$19.8 million in 2021.
- Business Quant data shows HCM's Operating Expenses at -$19.8 million in Q2 2021, -$144.8 million in Q1 2021, and -$100.9 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -19.77 Mn |
| Mar 31, 2021 | -144.76 Mn |
| Jun 30, 2020 | -100.87 Mn |
| Mar 31, 2020 | -84.06 Mn |
| Dec 31, 2019 | -91.78 Mn |
| Sep 30, 2019 | -85.29 Mn |
| Jun 30, 2019 | -262.43 Mn |
| Mar 31, 2019 | 88.22 Mn |
| Dec 31, 2018 | 77.28 Mn |
| Sep 30, 2018 | 73.60 Mn |
| Jun 30, 2018 | 233.23 Mn |
| Mar 31, 2018 | -77.36 Mn |